any specific abnormality in ultrastructure. Although some of the more recent observations have still to be followed up, there seems to be no reason to suppose that any of the biochemical abnormalities so far discovered have primary significance. It has been considered by some that the leakage of enzymes from the fibres denotes a defect in the membrane which is apparently not present in neurogenic muscle atrophy and is therefore likely to be a fundamental one. However, the observation that enzyme retention by fibres is readily upset by metabolic or mechanical damage (Zierler, 1958) would appear to make this less likely, although much more research on the factors involved in the passage of proteins across the sarcolemma is obviously necessary. It is by no means certain, even, that the primary defect in muscular dystrophy lies in the muscle itself, although this is the simpler assumption; the possibility of a myotoxin being produced elsewhere in the body or of a defect in the production by the body of a compound essential for the maintenance of the fibres has not been excluded. It is hoped that evidence on this important question may eventually come out of tissue culture studies. but culture of adult muscle is notoriously difficult and so far consistent results have not been obtained.
An inborn error of metabolism is a genetically determined lack of an enzyme (or of an enzymelike carrier substance involved in transport into or out of cells). Since the first description of such conditions by Garrod (1908) about 400 different inborn errors of metabolism and related conditions have been reported; related conditions include the storage diseases such as the lipidoses, "molecular diseases" such as the haemoglobin-opathies and bisalbuminaemia, and pharmacogenetic conditions such as pseudocholinesterase deficiency. A considerable number of inborn errors of metabolism are associated with disorders of the central nervous system -mental retardation, psychosis or neurological abnormality. The list is a formidable one and includes errors of the intermediary metabolism of amino acids, carbohydrates, lipids, porphyrins, purines, ... Member of the External Scientific Staff of the Medical Research Council.
metals, hormones and vitamins.
Among genetically determined transport defects Hartnup disease, the cerebro-oculo-renal syndrome and nephrogenic diabetes insipidus are associated with disorders of the central nervous system (Halvorsen & Halvorsen, 1963; Jepson & Spiro, 1960; Lowe, Terrey & MacLachlan, 1952; Ruess & Rosenthal, 1963) . A single example, phenylketonuria, brings out most clearly the features many of these diseases have in common.
Phenylketonuria: clinical features.
Children affected with phenylketonuria are normal at birth but suffer progressive mental deterioration and, by one or two years of age, two thirds of cases have an LQ. under 25 and very few an I.Q. over 60 (Knox, 1960; Jervis, 1963; Woolf, 1963) . (The few exceptions are considered below). These children continue to deteriorate intellectually over the years, though at a slower pace. The great majority live out their existences, 60 or 70 years in some cases, unable to care for themselves even in the simplest respect. In addition, over 90 % show neurological abnormalities on the E.E.G. and a quarter have frank epilepsy.
An aspect of phenylketonuria not always appreciated is that many patients show marked psychotic features. The higher grade patients often present with behaviour disorders rather than mental retardation, the more severely affected patients show a greater degree of withdrawal and autistic behaviour than is found in other mental defectives.
Early morphological investigations gave inconclusive answers to the question of whether or not any structural changes occurred in the brain, but chemical analysis for lipid components showed a clear deficiency of myelin in all phenylketonuric brains examined (Crome, Tymms & Woolf, 1962) . Biochemistry. Phenylketonuria consists in the absence or inactivity of phenylalanine hydroxylase (Armstrong, 1963; Woolf, 1963) . This enzyme normally occurs in the liver and converts phenylalanine to tyrosine. Since the main normal path of its metabolism is blocked, phenylalanine accumulates in the blood and tissues and, because of its abnormally high concentration, is transaminated to form phenylpyruvic acid, a reaction which normally proceeds at negligible speed. Some of the phenylpyruvic acid is converted to other substances -phenyl-lactic acid, phenylacetylglutamine, N-acetylphenylalanine, o-hydroxyphenylacetic acid, hippuric acid -which are excreted in the urine together with unchanged phenylpyruvic acid and phenylalanine. The enzymes which catalyse the production of these "abnormal" metabolites of phenylalanine are themselves normal and each of these substances is present in normal urine as a trace substance or in relatively low concentration. Inhibition by phenylalanine, or one ofits abnormal metabolites, of other enzymes or enzyme-like substances causes the urinary excretion of increased amounts of indolyl-Iactic acid, indolylpyruvic acid, indolylacetic acid and indican, the last two being associated with reduced absorption oftryptophan from the gut (Armstrong & Robinson, 1954; Schreier & Flaig, 1956; Jepson, personal communication; Bessman & Tada, 1960) .
Genetics. Phenylalanine hydroxylase is coded for by a gene on an autosome. Mutant alleles are either silent or code for a protein lacking the catalytic properties of phenylalanine hydroxylase A homozygote, with two such inactive genes, cannot synthesize active enzyme and suffers from phenylketonuria. The heterozygote has one normal gene which makes an almost normal amount of enzyme-the heterozygote therefore has practically normal biochemistry and suffers from no clinical abnormality. Phenylketonuria is, therefore, a classical Mendelian recessive character.
Treatment. In 1951 it was first suggested that the mental and neurological features of phenylketonuria were the result of an intoxication by phenylalanine or its abnormal metabolites and that treatment with a diet low in phenylalanine might be effective (Woolf & Vulliamy, 1951) . Such a diet was devised and has been used in treating many patients with phenylketonuria (Woolf, Griffiths, Moncrieff, Coates & Dillistone, 1958) . Provided treatment is started early in infancy and is carefully maintained, treated phenylketonurics grow into normal adults with no mental, physical or neurological abnormalities. Treatment later in childhood prevents further deterioration and often produces a marked neurological and behavioural improvement, with a rise in I.Q., but the intelligence does not always return to normal (Report of the Conference on Phenylketonuria, 1963).
Atypical phenylketonuria, occult phenylketonuria and maternalphenylketonuria. A few individuals with the genotype and biochemical error of phenylketonuria are of normal intelligence. In some cases, at least, the concentration of phenylalanine in the blood is lower than in more typical phenylketonurics, e.g. 7mg. phenylalanine per 100mi. plasma in an atypical phenylketonuric and from 20 to 40 mg. per lOOmi. in a typical patient (Woolf, Ounsted, Lee, Humphrey, Cheshire & Steed, 1961) . This correlation fits in with the intoxication theory; it must, however, be assumed that in atypical cases the relatively low concentration of phenylalanine in blood and tissues found in later childhood or adult life also applied in infancy. Some phenylketonurics excrete so little phenylpyruvic acid that it cannot be detected by simple tests, e.g. using Phenistix or ferric chloride. These occult phenylketonurics are all among the atypical group, i.e, clinically unaffected or little affected (Jervis, personal communication; Woolf et al., 1961) .
Few phenylketonurics are fertile, but some women with phenylketonuria have had children. Some of these children are clinically and biochemically normal, others are more or less mentally retarded, though they do not have phenylketonuria. Presumably in-utero exposure to a phenylketonuric milieu has affected the brains of the second group. This may introduce a problem when successfully treated girls with phenylketonuria grow up and raise families. Pathogenesis. The most important unsolved nroblem in phenylketonuria concerns its pathogenesis-e-i.e. how the biochemical abnormality produces mental deficiency, psychosis and neurological disorders. The intoxication theory has been proved correct by the success of treatment with a diet low in phenylalanine. Argument as to which of the abnormal metabolites is the toxic substance has, so far, proved rather sterile.
The finding that some myelin lipids were present in reduced amounts in the brains of phenylketonurics seemed to point clearly to interference with the laying down of myelin as the site of action of the toxic substance (Crome, Tymms & Woolf, 1962) . This correlates well with the fact that mental deterioration proceeds most rapidly during the first two years of life, the period when most of the myelin is being laid down.
There can be no doubt of the importance of noradrenaline and 5-hydroxytryptamine as neurohumoral agents in the central nervous system. The decarboxylases producing these hormones are inhibited by the abnormal metabolites of phenylalanine and smaller amounts of the hormones are formed in phenylketonuria (Weil-Malherbe, 1955; Fellman, 1956; Pare, Sandler & Stacey, 1957 , 1958 , 1959 Davison & Sandler, 1958) . This interference with the functioning of the central nervous system provides an alternative explanation of the mental deficiency etc. It fits in well with the improvement in behaviour etc. found within a few days of starting a diet low in phenylalanine.
The two theories may be combined by postulating depression of neurone function, following inhibition of DOPA-decarboxylase etc., leading to death of some neurones early in life. The axons of these neurones never form myelin sheaths. Further work on the morphology and physiology of the brain, particularly at the sub-cellular level, is necessary if we are to understand how these effects are brought about.
OtherInborn Errors of Metabolism
Leucinosis (maple syrup urine disease). In leucinosis there is complete absence, or inactivity, of the enzyme or enzymes decarboxylating the three a-keto-acids corresponding to leucine, isoleucine and valine (Menkes, 1959; MacKenzie & Woolf, 1959) . In consequence the main metabolic pathway for these branched chain amino acids is blocked; the three a-keto-acids accumulate and are partly converted to the corresponding amino acids and a-hydroxy acids. As in phenylketonuria, the patient with leucinosis is homozygous for a rare mutant gene and therefore cannot make the relevant enzyme or enzymes; the heterozygote is clinically and biochemically normal.
Leucinosis causes progressive and, usually, rapid cerebral degeneration. The infant is normal at birth but soon ceases to suck, fails to develop normally, shows increasing neurological dysfunction and usually dies in respiratory distress within a few months of birth. Morphologically, the brain is much more severely damaged than in phenylketonuria (Crome, Dutton & Ross, 1961) .
On the theory that leucinosis was also an intoxication of the central nervous system by substances accumulating because of the block in metabolism, treatment with a diet low in leucine, isoleucine and valine was suggested (MacKenzie & Woolf, 1959) . This has been successful in the four cases in which it was used.
Histidinaemia. Absence of the enzyme histidase causes the accumulation of histidine and its conversion to the abnormal metabolites imidazolylpyruvic acid and imidazolyl-lactic acid (Ghadimi, Partington & Hunter, 1962; La Du et al., 1963) . Affected individuals are often mentally normal apart from speech defects such as poor word memory and difficulties in articulation and language organization. However some patients are clearly mentally retarded and others have delayed motor development as well as speech defects (Gerritsen & Waisman, 1964) . It seems possible that the speech centre of the brain is specifically poisoned in histidinaemia. A diet low in histidine is being investigated.
Hartnup disease. In Hartnup disease there is a specific defect in the transport of certain amino acids from the lumen of the gut into the jejunal mucosa and from the glomerular filtrate into the proximal tubular epithelium (Milne et al., 1960) . Patients suffer cerebellar ataxia and other signs of nicotinamide deficiency. The slow absorption of tryptophan leads to its destruction by bacterial action in the gut, the indole so produced being absorbed and inhibiting tryptophan pyrrolase, thus reducing the amount of nicotinamide synthesized from the available tryptophan, itself reduced by poor intestinal absorption and urinary loss (Hooft, de Laey, Timmermans & Snoeck, 1964) .
Chronological relation of Inborn Errors of Metabolism to Mental Disease
Before birth many of the biochemical processes can be carried out for the foetus by the maternal tissues. A metabolite, provided it can cross cell membranes, does not accumulate even if the relevant enzyme is absent. After birth, absence of the enzyme causes a more or less rapid accumulation and this may damage the central nervous system.
Rapid accumulation, as in phenylketonuria, may depress the functioning of the brain virtually from birth, preventing the development of normal intelligence or even, as in leucinosis, leading to death. Slower accumulation, as of copper in Wilson's disease, may leave the child's intelligence unaffected but cause mental and neurological disease in adult life.
